Politics · Singapore Bureau
Indian billionaire's brain-imaging device sparks medical controversy
A wearable technology promoted by an Indian entrepreneur to monitor cerebral blood flow has drawn sharp criticism from medical professionals, with some dismissing it as unproven. The device, priced at around US$900, has become a flashpoint in debates over medical innovation and patient safety in South Asia.
LSN Singapore ·
The portable brain-monitoring device, which claims to track blood circulation in the cerebral cortex, has generated significant dispute within India's medical community. Prominent hepatologists and other specialists have questioned its efficacy and clinical validity, with one senior doctor describing it as potentially misleading to consumers seeking legitimate health solutions.
The billionaire-backed venture markets the tracker as a non-invasive tool for monitoring neurological health, targeting affluent consumers willing to adopt cutting-edge wellness technologies. However, medical experts have raised concerns about the lack of peer-reviewed research validating the device's purported capabilities and the risks of patients relying on unproven technology instead of conventional diagnostics.
The controversy reflects broader tensions across South and Southeast Asia regarding the pace of health technology adoption and the adequacy of regulatory oversight. While innovation in medical devices continues to accelerate, clinicians have called for stricter evidence standards before such products reach consumers, particularly given their high cost and potential to influence healthcare decisions.
Regulatory bodies in India have not yet issued formal statements on the device's approval status or claims. The dispute underscores the ongoing challenge faced by health authorities in the region to balance encouraging technological advancement with protecting public health and preventing the proliferation of unvalidated treatments.